Dextera Biosciences
Phase 1Pioneering a new category of drugs that precisely target the site of disease while remaining invisible to the rest of the body.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $5.5M
About
Pioneering a new category of drugs that precisely target the site of disease while remaining invisible to the rest of the body.
Biologics
Funding History
1Total raised:$5.5M
Seed$5.5MJun 15, 2022